Nuts consumption beneficial for preventing breast cancer: Study

According to the study, nut consumption is linked with lower risks of breast cancer recurrence or death.The findings of the study were published in the ‘International Journal of Cancer’.

Among 3,449 breast cancer survivors from the Shanghai Breast Cancer Survival Study, who completed a dietary assessment 5 years after diagnosis, there were 374 deaths during a median follow-up of 8.27 years after the dietary assessment.

Among 3,274 survivors without a previous recurrence at the time of their dietary assessment, 209 developed breast cancer-specific events, including recurrence, metastasis, or breast cancer mortality.

There was a dose-response pattern in the relationship between nut consumption and risk of breast cancer recurrence or death, with those consuming the highest amounts having the lowest risks.

Also, the association was stronger for survivors who had earlier stages of breast cancer than for those who had later stages.

 

 

 

AddThis Website Tools
Medically Speaking Team

Recent Posts

India’s Immunisation Coverage Soars from 73% to 95% in Two Years

Immunisation plays a crucial role in protecting children from life-threatening diseases. In the past two…

5 hours ago

Mounjaro vs. Ozempic: Which Is Safer for Weight Loss?

In recent years, new diabetes and weight loss medications have sparked widespread interest, particularly among…

6 hours ago

Nutraceuticals in India: Rising Popularity and Future Potential

Nutraceuticals, a fusion of "nutrition" and "pharmaceuticals," have emerged as a significant force in the…

6 hours ago

Statins and Ezetimibe: A Life-Saving Cholesterol-Lowering Combination

Heart disease remains one of the leading causes of death worldwide. For years, statins have…

7 hours ago

SARS-CoV-2: Still Circulating but Weaker, Say Experts

Five years after the COVID-19 pandemic brought the world to a standstill, the SARS-CoV-2 virus…

7 hours ago

Mounjaro Launched in India: Price & Impact on Diabetes and Obesity

Eli Lilly, a leading American pharmaceutical company, has launched its groundbreaking diabetes and obesity medication,…

2 days ago